Search
Jun 4, 2023
Antibody-drug conjugates at #ASCO23 with Seagen’s David Epstein
Seagen CEO David Epstein talks about moving antibody-drug conjugates into broader indications at #ASCO23.
Jan 11, 2023
Antibody-drug conjugates with David Epstein
Seagen's David Epstein talks about antibody-drug conjugates at #JPM23.